Cargando…

The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system

BACKGROUND: It is known that specimen collection followed by histopathological workup is the core of evidence-based medical therapy of musculoskeletal tumors. There exist many controversies about how a biopsy should be performed. While some centers recommend minimal invasive biopsy procedures, mostl...

Descripción completa

Detalles Bibliográficos
Autores principales: Dirks, Michael, Ewerbeck, Nicolas K., Ballhause, Tobias M., Weiß, Sebastian, Luebke, Andreas, Schlickewei, Carsten, Frosch, Karl-Heinz, Priemel, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827702/
https://www.ncbi.nlm.nih.gov/pubmed/36624456
http://dx.doi.org/10.1186/s12957-022-02883-w
_version_ 1784867103962038272
author Dirks, Michael
Ewerbeck, Nicolas K.
Ballhause, Tobias M.
Weiß, Sebastian
Luebke, Andreas
Schlickewei, Carsten
Frosch, Karl-Heinz
Priemel, Matthias
author_facet Dirks, Michael
Ewerbeck, Nicolas K.
Ballhause, Tobias M.
Weiß, Sebastian
Luebke, Andreas
Schlickewei, Carsten
Frosch, Karl-Heinz
Priemel, Matthias
author_sort Dirks, Michael
collection PubMed
description BACKGROUND: It is known that specimen collection followed by histopathological workup is the core of evidence-based medical therapy of musculoskeletal tumors. There exist many controversies about how a biopsy should be performed. While some centers recommend minimal invasive biopsy procedures, mostly the core needle biopsy (CNB), others prefer the incisional biopsy. PURPOSE OF THE STUDY: This study aimed to determine the accuracy of incisional biopsy for malignant tumors in the musculoskeletal system. Moreover, advantages and disadvantages to other biopsy methods are discussed. METHODS: This retrospective, single-center study about 844 incisional biopsies (benign and malignant) analysis the diagnostic accuracy of 332 malignant tumors, concerning the final histopathological result. In addition, surgical complications are analyzed to find the best way to plan and treat patients timely and correct. Secondary endpoints are the patients age, the pure operation time, as well as the type of tumor, and the subsequent therapy. RESULTS: In summary, incisional biopsy corresponded a sensitivity of 100% for malignancy in 844 incisional biopsies and a specificity of 97.6% in 332 malignant tumors, but it features greater operative expense (incision/suture 23.5 min) and the risk of general anesthesia. CONCLUSION: The method of biopsy should be tailored to the individual patient and the experience of the center performing the procedure.
format Online
Article
Text
id pubmed-9827702
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98277022023-01-10 The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system Dirks, Michael Ewerbeck, Nicolas K. Ballhause, Tobias M. Weiß, Sebastian Luebke, Andreas Schlickewei, Carsten Frosch, Karl-Heinz Priemel, Matthias World J Surg Oncol Research BACKGROUND: It is known that specimen collection followed by histopathological workup is the core of evidence-based medical therapy of musculoskeletal tumors. There exist many controversies about how a biopsy should be performed. While some centers recommend minimal invasive biopsy procedures, mostly the core needle biopsy (CNB), others prefer the incisional biopsy. PURPOSE OF THE STUDY: This study aimed to determine the accuracy of incisional biopsy for malignant tumors in the musculoskeletal system. Moreover, advantages and disadvantages to other biopsy methods are discussed. METHODS: This retrospective, single-center study about 844 incisional biopsies (benign and malignant) analysis the diagnostic accuracy of 332 malignant tumors, concerning the final histopathological result. In addition, surgical complications are analyzed to find the best way to plan and treat patients timely and correct. Secondary endpoints are the patients age, the pure operation time, as well as the type of tumor, and the subsequent therapy. RESULTS: In summary, incisional biopsy corresponded a sensitivity of 100% for malignancy in 844 incisional biopsies and a specificity of 97.6% in 332 malignant tumors, but it features greater operative expense (incision/suture 23.5 min) and the risk of general anesthesia. CONCLUSION: The method of biopsy should be tailored to the individual patient and the experience of the center performing the procedure. BioMed Central 2023-01-09 /pmc/articles/PMC9827702/ /pubmed/36624456 http://dx.doi.org/10.1186/s12957-022-02883-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Dirks, Michael
Ewerbeck, Nicolas K.
Ballhause, Tobias M.
Weiß, Sebastian
Luebke, Andreas
Schlickewei, Carsten
Frosch, Karl-Heinz
Priemel, Matthias
The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system
title The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system
title_full The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system
title_fullStr The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system
title_full_unstemmed The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system
title_short The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system
title_sort diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827702/
https://www.ncbi.nlm.nih.gov/pubmed/36624456
http://dx.doi.org/10.1186/s12957-022-02883-w
work_keys_str_mv AT dirksmichael thediagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT ewerbecknicolask thediagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT ballhausetobiasm thediagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT weißsebastian thediagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT luebkeandreas thediagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT schlickeweicarsten thediagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT froschkarlheinz thediagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT priemelmatthias thediagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT dirksmichael diagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT ewerbecknicolask diagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT ballhausetobiasm diagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT weißsebastian diagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT luebkeandreas diagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT schlickeweicarsten diagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT froschkarlheinz diagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem
AT priemelmatthias diagnosticaccuracyof332incisionalbiopsiesinpatientswithmalignanttumorsinthemusculoskeletalsystem